Women And Epilepsy: Reproductive Life And Epilepsy
January 2004
New to Valproic acid? There is a guide in the encyclopedia. Read the guide → 
Studysummary This review addresses various gender-specific challenges in managing women with epilepsy, such as AED-related cosmetic concerns and hormonal impacts on seizure frequency, but it reports no new clinical findings. Our plain-language summary of this paper — not a Tressless recommendation.
The document from 2004 discusses various reproductive and endocrine issues faced by women with epilepsy (WWE), focusing on the effects of antiepileptic drugs (AEDs) and the reproductive cycle. It highlights that AEDs can cause cosmetic side effects such as weight gain, particularly with valproate, and hair loss or excessive hair growth with valproate and phenytoin, respectively. The paper also notes that seizure frequency can fluctuate with menstrual cycles, a phenomenon known as catamenial epilepsy, which is often linked to hormonal changes and may be more pronounced during anovulatory cycles. Additionally, the interaction between AEDs and oral contraceptives, the impact of menopause on seizure frequency, and the effects of AEDs on fertility and bone metabolism are mentioned as concerns for WWE, although the document indicates that some of these areas require further study.
